UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer

Clinical cancer research, 2016-08, Vol.22 (15), p.3755-3763

2016

Link zum Volltext

Verfügbarkeit prüfen

High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program

Cancer, 2021-08, Vol.127 (16), p.3019-3028

2021

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive Genomic Profiling of Circulating Cell-Free DNA Distinguishes Focal MET Amplification from Aneuploidy in Diverse Advanced Cancers

Current oncology (Toronto), 2021-09, Vol.28 (5), p.3717-3728

2021

Link zum Volltext

Verfügbarkeit prüfen

Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice

Current oncology (Toronto), 2022-03, Vol.29 (3), p.2154-2164

2022

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal monitoring by next‐generation sequencing of plasma cell‐free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors

Cancer medicine (Malden, MA), 2022-08, Vol.11 (15), p.2944-2956

2022

Link zum Volltext

Verfügbarkeit prüfen

SY11-4. Clinical Evidence for Guardant360 in Patients with Advanced Stage Non-Small Cell Lung Cancer (NSCLC)

Japanese Journal of Lung Cancer, 2022-11, Vol.62 (6), p.508-508

Steve Olsen

2022

Link zum Volltext

Verfügbarkeit prüfen

FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC)

Journal of clinical medicine, 2022-04, Vol.11 (9), p.2475

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea

Cancer treatment and research communications, 2023-01, Vol.36, p.100715-100715, Article 100715

2023

Link zum Volltext

Verfügbarkeit prüfen

Potential mechanisms for thrombocytopenia development with trastuzumab emtansine (T-DM1)

Clinical cancer research, 2015-01, Vol.21 (1), p.123-133

2015

Link zum Volltext

Verfügbarkeit prüfen

Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system

European journal of cancer (1990), 2023-11, Vol.193, p.113310-113310, Article 113310

2023

Link zum Volltext

Verfügbarkeit prüfen

Combined genomic and epigenomic assessment of cell-free circulating tumour DNA (cfDNA) for cancer diagnosis and recurrence-risk assessment in early-stage lung cancer

Annals of oncology, 2019-10, Vol.30, p.v33

2019

Link zum Volltext

Verfügbarkeit prüfen

111P - Combined genomic and epigenomic assessment of cell-free circulating tumour DNA (cfDNA) for cancer diagnosis and recurrence-risk assessment in early-stage lung cancer

Annals of oncology, 2019-10, Vol.30, p.v33-v33

2019

Link zum Volltext

Verfügbarkeit prüfen

Missing Ingredients in Shared Decision-Making?

Psychiatric quarterly, 2019-06, Vol.90 (2), p.333-338

2019

Link zum Volltext

Verfügbarkeit prüfen

An Integrated Multiple-Analyte Pharmacokinetic Model to Characterize Trastuzumab Emtansine (T-DM1) Clearance Pathways and to Evaluate Reduced Pharmacokinetic Sampling in Patients with HER2-Positive Metastatic Breast Cancer

Clinical pharmacokinetics, 2013-08, Vol.52 (8), p.657-672

2013

Link zum Volltext

Verfügbarkeit prüfen

PATHOGENESIS AND EPIDEMIOLOGY OF BRUCELLOSIS IN YELLOWSTONE BISON: SEROLOGIC AND CULTURE RESULTS FROM ADULT FEMALES AND THEIR PROGENY

Journal of wildlife diseases, 2009-07, Vol.45 (3), p.729-739

2009

Link zum Volltext

Verfügbarkeit prüfen

Hepatic lipidosis in pregnant captive American bison (Bison bison)

Journal of veterinary diagnostic investigation, 2002-11, Vol.14 (6), p.512-515

2002

Link zum Volltext

Verfügbarkeit prüfen

Involvement of Progenitor Cells in Vascular Repair

Trends in Cardiovascular Medicine, 2003-11, Vol.13 (8), p.322-326

2003

Link zum Volltext

Verfügbarkeit prüfen

Abstract A135: T-DM1-induced thrombocytopenia results from impaired platelet production in a HER2-independent manner

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.A135-A135

2011

Link zum Volltext

Verfügbarkeit prüfen

111PCombined genomic and epigenomic assessment of cell-free circulating tumour DNA (cfDNA) for cancer diagnosis and recurrence-risk assessment in early-stage lung cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

PATHOGENESIS AND EPIDEMIOLOGY OF BRUCELLOSIS IN YELLOWSTONE BISON: SEROLOGIC AND CULTURE RESULTS FROM ADULT FEMALES AND THEIR PROGENY

Journal of wildlife diseases, 2009-01, Vol.45 (3), p.np-np

2009

Link zum Volltext

Verfügbarkeit prüfen

State Science and Technology Policy Advice: Issues, Opportunities, and Challenges: Summary of a National Convocation

National Academies Press, 2008

Olson, Steve

2008

Link zum Volltext

Verfügbarkeit prüfen

Bjørnøya brenner

Norsk tidsskrift for sjøvesen, 2008, Vol.123 (5)

Olsen, Steve

2008

Link zum Volltext

Verfügbarkeit prüfen

Kystvakten - en hovedaktør i det norsk-russiske samarbeidet

Norsk tidsskrift for sjøvesen, 2006, Vol.121 (6)

Olsen, Steve

2006

Link zum Volltext

Verfügbarkeit prüfen

167 TOXIC MYOCARDIAL DEPRESSION

Pediatric research, 1985-04, Vol.19 (4), p.138-138A

1985

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(168)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer

High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program

Comprehensive Genomic Profiling of Circulating Cell-Free DNA Distinguishes Focal MET Amplification from Aneuploidy in Diverse Advanced Cancers

Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice

Longitudinal monitoring by next‐generation sequencing of plasma cell‐free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors

SY11-4. Clinical Evidence for Guardant360 in Patients with Advanced Stage Non-Small Cell Lung Cancer (NSCLC)

FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC)

Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea

Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial

Potential mechanisms for thrombocytopenia development with trastuzumab emtansine (T-DM1)

Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system

Combined genomic and epigenomic assessment of cell-free circulating tumour DNA (cfDNA) for cancer diagnosis and recurrence-risk assessment in early-stage lung cancer

111P - Combined genomic and epigenomic assessment of cell-free circulating tumour DNA (cfDNA) for cancer diagnosis and recurrence-risk assessment in early-stage lung cancer

Missing Ingredients in Shared Decision-Making?

An Integrated Multiple-Analyte Pharmacokinetic Model to Characterize Trastuzumab Emtansine (T-DM1) Clearance Pathways and to Evaluate Reduced Pharmacokinetic Sampling in Patients with HER2-Positive Metastatic Breast Cancer

PATHOGENESIS AND EPIDEMIOLOGY OF BRUCELLOSIS IN YELLOWSTONE BISON: SEROLOGIC AND CULTURE RESULTS FROM ADULT FEMALES AND THEIR PROGENY

Hepatic lipidosis in pregnant captive American bison (Bison bison)

Involvement of Progenitor Cells in Vascular Repair

Abstract A135: T-DM1-induced thrombocytopenia results from impaired platelet production in a HER2-independent manner

111PCombined genomic and epigenomic assessment of cell-free circulating tumour DNA (cfDNA) for cancer diagnosis and recurrence-risk assessment in early-stage lung cancer

PATHOGENESIS AND EPIDEMIOLOGY OF BRUCELLOSIS IN YELLOWSTONE BISON: SEROLOGIC AND CULTURE RESULTS FROM ADULT FEMALES AND THEIR PROGENY

State Science and Technology Policy Advice: Issues, Opportunities, and Challenges: Summary of a National Convocation

Bjørnøya brenner

Kystvakten - en hovedaktør i det norsk-russiske samarbeidet

167 TOXIC MYOCARDIAL DEPRESSION

Suchergebnisse filtern